Page last updated: 2024-10-21

3-methoxytyramine and Epilepsy

3-methoxytyramine has been researched along with Epilepsy in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chanut, E1
Labarthe, B1
Lacroix, B1
Noda, A1
Gasdeblay, S1
Bondier, JR1
Versaux-Botteri, C1

Other Studies

1 other study available for 3-methoxytyramine and Epilepsy

ArticleYear
Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina.
    Brain research, 2006, Jan-27, Volume: 1070, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amino Acids; Animals; Animals, Newborn; Biogenic Monoamines;

2006